CNET también está disponible en español.
Don't show this again
Hambrecht & Quist downgraded antivirus software maker Dr. Solomon's Group to "hold" from "buy," based on valuation. The stock is trading at 39 times Hambrecht's calendar 1998 estimate, vs. growth forecasts of 32 percent. The firm sees the computer antivirus market remaining strong and the company continuing to make progress, but sees "fierce competition" ahead, as reported by Reuters. Dr. Solomon's stock has fallen more than 20 percent this week.